Glutathione: adverse events and evidence limits
A crossover study in eight patients with mild asthma observed airway narrowing, cough and breathlessness after nebulized glutathione. [1]
This short inhalation-challenge observation does not establish oral or injectable-formulation risks. [1]
What the studies reported
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Airway narrowing (bronchoconstriction) | Eight patients with mild asthma, nebulized glutathione, crossover study | Observed after a short inhalation challenge; no frequency given; the observation does not establish oral or injectable-formulation risks | [1] |
| Cough | The same patients | Observed after the inhalation challenge; no frequency given | [1] |
| Breathlessness | The same patients | Observed after the inhalation challenge; no frequency given | [1] |
References
- R M Marrades et al. (1997). Nebulized glutathione induces bronchoconstriction in patients with mild asthma https://doi.org/10.1164/ajrccm.156.2.9611001.